The cost of diabetes in the presence of comorbid conditions.
Disease management programs usually focus on the target disease, with little emphasis on clinical comorbidity. The research presented here used retrospective analysis to determine the incremental costs of diabetes to a state Medicaid program when diabetes occurred with other common chronic illnesses. The study revealed that the incremental costs of diabetes were influenced by the costs of the chronic illnesses associated with diabetes. The following methodology is intended to improve the benchmarking and evaluation of diabetes disease management programs.
Garis
Robert I
RI
Department of Pharmacy Sciences, Creighton University School of Pharmacy, Allied Health Professions, Omaha, USA. rgaris@creighton.edu
Shara
Michael A
MA
Farmer
Kevin C
KC
Horrell
James F
JF
Arora
Michael
M
D000465:Algorithms; D002908:Chronic Disease / Q000191:economics; D015897:Comorbidity; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000191:economics*; D019468:Disease Management; D017048:Health Care Costs / Q000706:statistics & numerical data; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006801:Humans; D008329:Managed Care Programs / Q000191:economics; D008484:Medicaid / Q000191:economics / Q000706:statistics & numerical data*; D009825:Oklahoma; D018579:Patient Selection; D012189:Retrospective Studies; D013221:State Health Plans / Q000191:economics; D014481:United States